Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS

Autor: Mariángeles Kovacs, Joseph S. Beckman, Ying Si, Ivan C. Moura, Olivier Hermine, Peter H. King, Valentina Varela, Sofía Ibarburu, Yuri Kwon, Emiliano Trias, Luis Barbeito
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Male
Pathology
medicine.medical_specialty
Neutrophils
Pyridines
Neuromuscular Junction
Inflammation
Neuromuscular junction
Cell Degranulation
Extensor digitorum longus muscle
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Superoxide Dismutase-1
Piperidines
Medicine
Animals
Humans
Mast Cells
Amyotrophic lateral sclerosis
Muscle
Skeletal

Protein Kinase Inhibitors
Neuroinflammation
Denervation
Motor Neurons
business.industry
Superoxide Dismutase
Masitinib
Amyotrophic Lateral Sclerosis
General Medicine
Mast cell
medicine.disease
Axons
Rats
Disease Models
Animal

Thiazoles
030104 developmental biology
medicine.anatomical_structure
Treatment Outcome
chemistry
Neutrophil Infiltration
Benzamides
medicine.symptom
Rats
Transgenic

business
030217 neurology & neurosurgery
Research Article
Popis: Neuroinflammation is a recognized pathogenic mechanism underlying motor neuron degeneration in amyotrophic lateral sclerosis (ALS), but the inflammatory mechanisms influencing peripheral motor axon degeneration remain largely unknown. A recent report showed a pathogenic role for c-Kit-expressing mast cells mediating inflammation and neuromuscular junction denervation in muscles from SOD1G93A rats. Here, we have explored whether mast cells infiltrate skeletal muscles in autopsied muscles from ALS patients. We report that degranulating mast cells were abundant in the quadriceps muscles from ALS subjects but not in controls. Mast cells were associated with myofibers and motor endplates and, remarkably, interacted with neutrophils forming large extracellular traps. Mast cells and neutrophils were also abundant around motor axons in the extensor digitorum longus muscle, sciatic nerve, and ventral roots of symptomatic SOD1G93A rats, indicating that immune cell infiltration extends along the entire peripheral motor pathway. Postparalysis treatment of SOD1G93A rats with the tyrosine kinase inhibitor drug masitinib prevented mast cell and neutrophil infiltration, axonal pathology, secondary demyelination, and the loss of type 2B myofibers, compared with vehicle-treated rats. These findings provide further evidence for a yet unrecognized contribution of immune cells in peripheral motor pathway degeneration that can be therapeutically targeted by tyrosine kinase inhibitors.
Databáze: OpenAIRE